+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rapid Test Market Analysis, By Product Type Rapid Test Product) By Application By End Use, Forecasts To 2026

  • ID: 5356034
  • Report
  • November 2019
  • Region: Global
  • 152 pages
  • Reports and Data

FEATURED COMPANIES

  • Akers Biosciences Inc.
  • Bio-rad Laboratories Inc.
  • Cepheid Inc.
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
Growing adoption of rapid test technologies owing to stringent food-safety regulations implemented by government of various countries is a key factor driving market revenue growth.

Market Size - USD 13.71 Billion in 2020, Market Growth - CAGR of 7.3%, Market Trends - Increasing prevalence of various infectious and chronic diseases across the globe.

The global rapid test market size is expected to reach USD 24.26 Billion in 2028, and register a CAGR of 7.3% during the forecast period. Increasing global food trade, growing demand for processed foods and complexity of food supply chain, and increasing public investment in various countries for food security practices are some of the major factors expected to drive growth of the global rapid test market.

Increasing need for preliminary screening in medical facilities, growing need for diagnostics, increasing adoption of rapid tests in healthcare sector, increasing preference and need for early diagnosis of diseases, high prevalence of infectious diseases, and demand for low cost diagnostics with highest accuracy are other major factors boosting market growth to a significant extent. These tests offer benefits such as stability at extremely high temperatures and results in short span of time.

Rapid tests are used in various industries to obtain more reliable test results in order to ensure safety of food products and to prevent foodborne illness from contaminants including veterinary drugs, pathogens, and induced chemicals, among others. These contaminants can cause hazardous infectious diseases.

Growing adoption of rapid test technologies owing to stringent food-safety regulations implemented by government of various countries is a key factor driving market revenue growth.

Market Size - USD 13.71 Billion in 2020, Market Growth - CAGR of 7.3%, Market Trends - Increasing prevalence of various infectious and chronic diseases across the globe.

The global rapid test market size is expected to reach USD 24.26 Billion in 2028, and register a CAGR of 7.3% during the forecast period. Increasing global food trade, growing demand for processed foods and complexity of food supply chain, and increasing public investment in various countries for food security practices are some of the major factors expected to drive growth of the global rapid test market.

Increasing need for preliminary screening in medical facilities, growing need for diagnostics, increasing adoption of rapid tests in healthcare sector, increasing preference and need for early diagnosis of diseases, high prevalence of infectious diseases, and demand for low cost diagnostics with highest accuracy are other major factors boosting market growth to a significant extent. These tests offer benefits such as stability at extremely high temperatures and results in short span of time.

Rapid tests are used in various industries to obtain more reliable test results in order to ensure safety of food products and to prevent foodborne illness from contaminants including veterinary drugs, pathogens, and induced chemicals, among others. These contaminants can cause hazardous infectious diseases.

Some Key Findings From the Report:
  • Among the product type segments, the professional rapid test product segment accounted for the largest revenue share of 57.2% in 2020.
  • North America market accounted for major revenue share in 2020, and is expected to continue with its dominance over the forecast period.
  • The Asia Pacific market size was USD 3,154.3 Million in 2020.
  • Key players profiled in the report include Akers Biosciences, Inc., Alere Inc. (Abbott Laboratories), Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc., Quidel Corporation, and Roche Diagnostics. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global rapid test market is segmented on the basis of product type, application, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2018 - 2028)
  • Over-the-Counter (OTC) Rapid Test Product
  • Professional Rapid Test Product
Application Outlook (Revenue, USD Billion; 2018 - 2028)
  • Infectious Disease
  • Cardiology
  • Oncology
  • Pregnancy & Fertility
  • Toxicology
  • Glucose Monitoring
  • Others
End Use Outlook (Revenue, USD Billion; 2018 - 2028)
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Others
Region Outlook (Revenue, USD Billion; 2018 - 2028)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Rapid Test Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Rapid Test Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
  • Among the product type segments, the professional rapid test product segment accounted for the largest revenue share of 57.2% in 2020.
  • North America market accounted for major revenue share in 2020, and is expected to continue with its dominance over the forecast period.
  • The Asia Pacific market size was USD 3,154.3 Million in 2020.
  • Key players profiled in the report include Akers Biosciences, Inc., Alere Inc. (Abbott Laboratories), Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc., Quidel Corporation, and Roche Diagnostics. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global rapid test market is segmented on the basis of product type, application, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2018 - 2028)
  • Over-the-Counter (OTC) Rapid Test Product
  • Professional Rapid Test Product
Application Outlook (Revenue, USD Billion; 2018 - 2028)
  • Infectious Disease
  • Cardiology
  • Oncology
  • Pregnancy & Fertility
  • Toxicology
  • Glucose Monitoring
  • Others
End Use Outlook (Revenue, USD Billion; 2018 - 2028)
  • Hospital & Clinic
  • Diagnostic Laboratory
  • Home Care
  • Others
Region Outlook (Revenue, USD Billion; 2018 - 2028)
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Rapid Test Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Rapid Test Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Akers Biosciences Inc.
  • Bio-rad Laboratories Inc.
  • Cepheid Inc.
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 - 2026

Chapter 3. Indicative Metrics
3.1. Increase in awareness regarding early diagnosis of disease
3.2. Prevalence of infectious diseases

Chapter 4. Rapid Test Segmentation & Impact Analysis
4.1. Rapid Test Segmentation Analysis
4.2. Rapid Test Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Rapid Test Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Growing geriatric population
4.4.1.2. Increase in development of healthcare sector
4.4.1.3. Favorable government policies
4.4.1.4. Increase in investments in R&D for diagnosis
4.4.2. Market restraint analysis
4.4.2.1. Lack of awareness
4.4.2.2. Expensive treatments
4.5. Key opportunities prioritized
4.6. Rapid Test Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Rapid Test PESTEL Analysis

Chapter 5. Rapid Test Market By Product Type Insights & Trends
5.1. Rapid Test Type dynamics & Market Share, 2018 & 2026
5.2. Over-the-Counter (OTC) product
5.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.3. Professional Rapid Test Product
5.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 6. Rapid Test Market By Application Insights & Trends
6.1. Rapid Test Application Type dynamics & Market Share, 2018 & 2026
6.2. Infectious Disease Skin conditions
6.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.3. Cardiology Internal Applications
6.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.4. Oncology Nerve disorders
6.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.5. Pregnancy & Fertility Psychiatric Applications
6.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.6. Toxicology Irritation and allergic reactions
6.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.7. Glucose Monitoring Irritation and allergic reactions
6.7.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.7.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.8. Others Irritation and allergic reactions
6.8.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.8.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 7. Rapid Test Market By End Use Insights & Trends
7.1. Rapid Test End Use dynamics & Market Share, 2018 & 2026
7.2. Hospitals & Clinics
7.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3. Diagnostics Laboratory
7.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.4. Home Care
7.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.5. Others
7.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 8. Rapid Test Market Regional Outlook
8.1. Rapid Test Market share by region, 2018 & 2026
8.2. North America
8.2.1. North America Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.2. North America Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.2.3. North America Rapid Test Market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.2.4. North America Rapid Test Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.2.5. U.S.
8.2.5.1. U.S. Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.5.2. U.S. Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.2.5.3. U.S. Rapid Test Market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.2.5.4. U.S. Rapid Test Market estimates and forecast by End use, 2016 - 2026, (USD Million)
8.2.6. Canada
8.2.6.1. Canada Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.6.2. Canada Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.2.6.3. Canada Rapid Test Market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.2.6.4. Canada Rapid Test Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3. Europe
8.3.1. Europe Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.2. Europe Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.3. Europe Rapid Test Market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.4. Europe Rapid Test Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.5. Germany
8.3.5.1. Germany Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.5.2. Germany Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.5.3. Germany Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.5.4. Germany Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.6. France
8.3.6.1. France Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.6.2. France Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.6.3. France Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.6.4. France Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.7. U.K.
8.3.7.1. U.K Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.3.7.2. U.K Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.7.3. U.K. Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.7.4. U.K. Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.8. Spain
8.3.8.1. Spain Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.3.8.2. Spain Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.8.3. Spain. Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.8.4. Spain Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.9. Italy
8.3.9.1. Italy Rapid Test Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.9.2. Italy Rapid Test Market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.9.3. Italy Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.9.4. Italy Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.3.10.2. Rest of Europe Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.3.10.3. Rest of Europe Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.3.10.4. Rest of Europe Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.4.2. Asia Pacific Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.4.3. Asia Pacific Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.4.4. Asia Pacific Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.5. China
8.4.5.1. China Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.4.5.2. China Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.4.5.3. China Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.4.5.4. China Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.6. Japan
8.4.6.1. Japan Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.4.6.2. Japan Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.4.6.3. Japan Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.4.6.4. Japan Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.7. India
8.4.7.1. India Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.4.7.2. India Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.4.7.3. India Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.4.7.4. India Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.8. Rest of Asia Pacific
8.4.8.1. Rest of Asia Pacific Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.4.8.2. Rest of Asia Pacific Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.4.8.3. Rest of Asia Pacific Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.4.8.4. Rest of Asia Pacific Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.5. Middle East & Africa
8.5.1. Middle East and Africa Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.5.2. Middle East and Africa Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.5.3. Middle East and Africa Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.5.4. Middle East and Africa Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.6. Latin America
8.6.1. Latin America Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.6.2. Latin America Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.6.3. Latin America Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.6.4. Latin America Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.6.5. Brazil
8.6.5.1. Brazil Rapid Test market estimates and forecast, 2016 - 2026, (USD Million)
8.6.5.2. Brazil Rapid Test market estimates and forecast by Product Type, 2016 - 2026, (USD Million)
8.6.5.3. Brazil Rapid Test market estimates and forecast by Application, 2016 - 2026, (USD Million)
8.6.5.4. Brazil Rapid Test market estimates and forecast by End Use, 2016 - 2026, (USD Million)

Chapter 9. Competitive Landscape
9.1. Market Revenue Share by Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Strategy Benchmarking
9.5. Vendor Landscape

Chapter 10. Company Profiles
10.1. Akers Biosciences, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Length Benchmarking
10.1.4. Strategic Initiatives
10.2. Alere Inc. (Abbott Laboratories)
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Length Benchmarking
10.2.4. Strategic Initiatives
10.3. Becton, Dickinson and Company
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Length Benchmarking
10.3.4. Strategic Initiatives
10.4. Bio-rad Laboratories, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Length Benchmarking
10.4.4. Strategic Initiatives
10.5. Cepheid, Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Length Benchmarking
10.5.4. Strategic Initiatives
10.6. Hologic, Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Length Benchmarking
10.6.4. Strategic Initiatives
10.7. Meridian Bioscience, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Length Benchmarking
10.7.4. Strategic Initiatives
10.8. OraSure Technologies, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Length Benchmarking
10.8.4. Strategic Initiatives
10.9. Quidel Corporation
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Length Benchmarking
10.9.4. Strategic Initiatives
10.10. Roche Diagnostics
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Length Benchmarking
10.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Akers Biosciences Inc.
  • Alere Inc. (Abbott Laboratories)
  • Becton Dickinson and Company
  • Bio-rad Laboratories Inc.
  • Cepheid Inc.
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Quidel Corporation
  • Roche Diagnostics.
Note: Product cover images may vary from those shown
Adroll
adroll